CRDL vs. ITH, FRX, VBV, CUS, AIM, IPA, APM, GXE, GPH, and MDNA
Should you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include International Tower Hill Mines (ITH), Fennec Pharmaceuticals (FRX), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), ImmunoPrecise Antibodies (IPA), Andean Precious Metals (APM), Gear Energy (GXE), Graphite One (GPH), and Medicenna Therapeutics (MDNA). These companies are all part of the "pharmaceutical products" industry.
Cardiol Therapeutics vs. Its Competitors
International Tower Hill Mines (TSE:ITH) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.
International Tower Hill Mines has a beta of 0.914615, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 0.954809, suggesting that its share price is 5% less volatile than the S&P 500.
6.0% of International Tower Hill Mines shares are held by institutional investors. Comparatively, 0.8% of Cardiol Therapeutics shares are held by institutional investors. 0.5% of International Tower Hill Mines shares are held by insiders. Comparatively, 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
International Tower Hill Mines is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Cardiol Therapeutics had 2 more articles in the media than International Tower Hill Mines. MarketBeat recorded 2 mentions for Cardiol Therapeutics and 0 mentions for International Tower Hill Mines. Cardiol Therapeutics' average media sentiment score of 0.71 beat International Tower Hill Mines' score of 0.00 indicating that Cardiol Therapeutics is being referred to more favorably in the news media.
International Tower Hill Mines' return on equity of -5.82% beat Cardiol Therapeutics' return on equity.
Summary
International Tower Hill Mines and Cardiol Therapeutics tied by winning 5 of the 10 factors compared between the two stocks.
Get Cardiol Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardiol Therapeutics Competitors List
Related Companies and Tools
This page (TSE:CRDL) was last updated on 9/13/2025 by MarketBeat.com Staff
